Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Criteo S.A.CRTO · Entity 291 | Director | November 22, 2024 | November 22, 2024 |
| RADISYS CORPRSYS · Entity 161880 | Director | December 07, 2017 | December 08, 2017 |
| SEQUANS COMMUNICATIONSSQNS · Entity 7292 | Director | March 25, 2026 | March 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Criteo S.A.
Report date November 22, 2024 · Filed November 22, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 50,631 |
Reported balance
After 2024-11-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-11-22 · Grant · Acquired 4,750 · Balance 50,631 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person. F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person.
F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
RADISYS CORP
Report date December 07, 2017 · Filed December 08, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 110,218 |
Reported balance
After 2017-12-07 transaction · row 1
1 source rowRow 1 · 2017-12-07 · Exercise / conversion · Acquired 6,872 · Balance 110,218 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 13,743 |
Reported balance
After 2017-12-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-12-07 · Exercise / conversion · Disposed 6,872 · Balance 13,743 F1: Restricted stock units vest 25% of the total shares on each of the following dates: September 7, 2017, December 7, 2017, March 7, 2018 and June 7, 2018, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests. F2: N/A |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units vest 25% of the total shares on each of the following dates: September 7, 2017, December 7, 2017, March 7, 2018 and June 7, 2018, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests.
F2: N/A
SEQUANS COMMUNICATIONS
Report date March 25, 2026 · Filed March 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.13 · Expires 2034-06-28 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-25 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2035-06-30 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-25 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.65 · Expires 2032-06-24 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-25 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $2.89 · Expires 2029-07-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-25 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $3.31 · Expires 2027-07-03 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-25 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.51 · Expires 2030-06-29 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-25 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance Not disclosed F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.49 · Expires 2031-06-25 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-25 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance Not disclosed F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.86 · Expires 2026-06-29 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-25 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance Not disclosed F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.54 · Expires 2033-06-27 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-25 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance Not disclosed F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $2.04 · Expires 2028-07-02 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-25 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance Not disclosed F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share |
Filing footnotes · ownership attribution and instrument terms
F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 22, 2024 Filed Nov 22, 2024 16:09 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 4,750 | $39.20 | $186,200.00 |
DisclosureSEC source: 0001576427-24-000136 · wk-form4_1732309732.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,631 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 16:13 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 6,000 | $33.94 | $203,640.00 |
DisclosureSEC source: 0001576427-24-000033 · wk-form4_1710274413.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,881 F1 · security: The Ordinary shares may be represented by American Depository Shares, each of which represents one Ordinary share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 16:02 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 10,200 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001576427-23-000007 · wf-form4_167649493455472.xml · derivative · entry 2 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,200 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. Warrant is set to expire on March 6, 2023. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 16:02 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 10,200 | $10.34 | $105,468.00 |
DisclosureSEC source: 0001576427-23-000007 · wf-form4_167649493455472.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.34 using the exchange rate as of February 13, 2023 (1.00 = $0.933). F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| December 02, 2022 Filed Dec 2, 2022 16:10 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 7,632 | $26.90 | $205,300.80 |
DisclosureSEC source: 0001576427-22-000118 · wf-form4_167001539890750.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,681 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.86 to $26.90 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F4 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 16:09 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 10,400 | $0.00 Strike: $8.13 | $0.00 |
DisclosureSEC source: 0001576427-22-000087 · wf-form4_166672854460256.xml · derivative · entry 2 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,400 shares Expires 2022-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 8.28 euros. The U.S. dollar equivalent of the exercise price is $8.13 using the exchange rate as of October 21, 2022 (1.00 = $0.983). F4 · derivative.exercise_date: Warrant granted on October 25, 2012. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 16:09 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 10,400 | $8.13 | $84,552.00 |
DisclosureSEC source: 0001576427-22-000087 · wf-form4_166672854460256.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the non-employee warrant is 8.28 euros. The U.S. dollar equivalent of the exercise price is $8.13 using the exchange rate as of October 21, 2022 (1.00 = $0.983). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| December 17, 2021 Filed Dec 20, 2021 16:10 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 3,857 | $40.46 | $156,060.78 |
DisclosureSEC source: 0001576427-21-000082 · wf-form4_164003461375133.xml · nonDerivative · entry 2 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,649 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| December 17, 2021 Filed Dec 20, 2021 16:10 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 492 | $39.30 | $19,334.27 |
DisclosureSEC source: 0001576427-21-000082 · wf-form4_164003461375133.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,792 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 16:05 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 7,300 | $19.06 | $139,108.80 |
DisclosureSEC source: 0001576427-20-000114 · wf-form4_160694311554416.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,300 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| October 24, 2019 Filed Oct 28, 2019 16:06 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 26,420 | $7.57 Strike: $19.41 | $199,999.40 |
DisclosureSEC source: 0001576427-19-000093 · wf-form4_157229316696924.xml · derivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,420 Underlying: Ordinary Shares · 26,420 shares Expires 2029-10-23 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 17.44 Euros. The U.S. dollar equivalent of the exercise price is $19.41 using the European Central Bank rate as of October 22, 2019 (1.00 = $1.1130), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants. F4 · price: The subscription price of the non-employee warrant is $7.57. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on October 24, 2020 and an additional 1/16th of the grant will vest quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 16:17 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 25,000 | $7.87 Strike: $22.45 | $196,750.00 |
DisclosureSEC source: 0001576427-18-000090 · wf-form4_154214382515383.xml · derivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2028-10-25 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 19.71 Euros. The U.S. dollar equivalent of the exercise price is $22.45 using the European Central Bank rate as of October 24, 2018 (1.00 = $1.1389), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants. F4 · price: The subscription price of the non-employee warrant is $7.87. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on October 25, 2019 and an additional 1/16th of the grant will vest quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 17:27 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionRestricted Stock Units · Derivative | 6,872 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000873044-17-000104 · edgardoc.xml · derivative · entry 2 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,743 Underlying: Common Stock · 6,872 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 7, 2017, December 7, 2017, March 7, 2018 and June 7, 2018, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests. F2 · derivative.expiration_date: N/A Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 17:27 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionCommon Stock | 6,872 | $0.00 | $0.00 |
DisclosureSEC source: 0000873044-17-000104 · edgardoc.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:29 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 12,225 | $16.36 Strike: $42.19 | $200,001.00 |
DisclosureSEC source: 0001209191-17-058304 · doc4.xml · derivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,225 Underlying: Ordinary Shares · 12,225 shares Expires 2027-10-26 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 35.80 euros. The U.S. dollar equivalent of the exercise price is $42.19 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). F4 · price: The subscription price of the non-employee warrant is 13.88 euros. The U.S. dollar equivalent of the exercise price is $16.36 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). The subscription price was satisfied by offset from fees otherwise payable to the reporting person by the Company for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| September 07, 2017 Filed Sep 8, 2017 16:20 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionRestricted Stock Units · Derivative | 6,872 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000873044-17-000086 · edgardoc.xml · derivative · entry 2 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,615 Underlying: Common Stock · 6,872 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 7, 2017, December 7, 2017, March 7, 2018 and June 7, 2018, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests. F2 · derivative.expiration_date: N/A Read SEC document |
| September 07, 2017 Filed Sep 8, 2017 16:20 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionCommon Stock | 6,872 | $0.00 | $0.00 |
DisclosureSEC source: 0000873044-17-000086 · edgardoc.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 14:38 UTC | RADISYS CORP RSYS · Entity 161880 | GrantRestricted Stock Units · Derivative | 27,487 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000873044-17-000053 · edgardoc.xml · derivative · entry 3 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,487 Underlying: Common Stock · 27,487 shares Expires not disclosed F3 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 7, 2017, December 7, 2017, March 7, 2018 and June 7, 2018, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests. F2 · derivative.expiration_date: N/A Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 14:38 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionRestricted Stock Units · Derivative | 4,057 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000873044-17-000053 · edgardoc.xml · derivative · entry 2 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,057 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 8, 2016, December 8, 2016, March 8, 2017 and June 8, 2017, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests. F2 · derivative.expiration_date: N/A Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 14:38 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionCommon Stock | 4,057 | $0.00 | $0.00 |
DisclosureSEC source: 0000873044-17-000053 · edgardoc.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2017 Filed Jun 5, 2017 17:11 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 10,000 | $0.00 Strike: $9.25 | $0.00 |
DisclosureSEC source: 0001576427-17-000112 · wf-form4_149669710129617.xml · derivative · entry 3 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Underlying: Ordinary Shares · 10,000 shares Expires 2022-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 8.28 euros. The U.S. dollar equivalent of the exercise price is $9.25 using the Federal Reserve Bank of New York noon buying rate for May 26, 2017 (1.00 = $1.1170). F5 · derivative.exercise_date: Warrant granted on October 25, 2012. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| June 02, 2017 Filed Jun 5, 2017 17:11 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 10,000 | $52.63 | $526,300.00 |
DisclosureSEC source: 0001576427-17-000112 · wf-form4_149669710129617.xml · nonDerivative · entry 2 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.31 to $52.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4 F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| June 02, 2017 Filed Jun 5, 2017 17:11 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 10,000 | $9.25 | $92,500.00 |
DisclosureSEC source: 0001576427-17-000112 · wf-form4_149669710129617.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the non-employee warrant is 8.28 euros. The U.S. dollar equivalent of the exercise price is $9.25 using the Federal Reserve Bank of New York noon buying rate for May 26, 2017 (1.00 = $1.1170). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 17:05 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionRestricted Stock Units · Derivative | 4,057 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000873044-17-000021 · edgardoc.xml · derivative · entry 2 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,057 Underlying: Common Stock · 4,057 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 8, 2016, December 8, 2016, March 8, 2017 and June 8, 2017, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests. F2 · derivative.expiration_date: N/A Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 17:05 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionCommon Stock | 4,057 | $0.00 | $0.00 |
DisclosureSEC source: 0000873044-17-000021 · edgardoc.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2016 Filed Dec 9, 2016 18:47 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionRestricted Stock Units · Derivative | 4,057 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000873044-16-000258 · edgardoc.xml · derivative · entry 2 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,114 Underlying: Common Stock · 4,057 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 8, 2016, December 8, 2016, March 8, 2017 and June 8, 2017, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests. F2 · derivative.expiration_date: N/A Read SEC document |
| December 08, 2016 Filed Dec 9, 2016 18:47 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionCommon Stock | 4,057 | $0.00 | $0.00 |
DisclosureSEC source: 0000873044-16-000258 · edgardoc.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 14:27 UTC | RADISYS CORP RSYS · Entity 161880 | PurchaseCommon Stock | 7,472 | $4.02 | $30,037.44 |
DisclosureSEC source: 0000873044-16-000253 · edgardoc.xml · nonDerivative · entry 5 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,303 Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 14:27 UTC | RADISYS CORP RSYS · Entity 161880 | PurchaseCommon Stock | 1,600 | $4.01 | $6,416.00 |
DisclosureSEC source: 0000873044-16-000253 · edgardoc.xml · nonDerivative · entry 4 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,831 Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 14:27 UTC | RADISYS CORP RSYS · Entity 161880 | PurchaseCommon Stock | 100 | $4.00 | $400.00 |
DisclosureSEC source: 0000873044-16-000253 · edgardoc.xml · nonDerivative · entry 3 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,231 Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 14:27 UTC | RADISYS CORP RSYS · Entity 161880 | PurchaseCommon Stock | 100 | $3.99 | $399.00 |
DisclosureSEC source: 0000873044-16-000253 · edgardoc.xml · nonDerivative · entry 2 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,131 Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 14:27 UTC | RADISYS CORP RSYS · Entity 161880 | PurchaseCommon Stock | 728 | $3.98 | $2,897.44 |
DisclosureSEC source: 0000873044-16-000253 · edgardoc.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,031 Read SEC document |
| October 27, 2016 Filed Oct 28, 2016 16:17 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 13,185 | $0.00 Strike: $36.92 | $0.00 |
DisclosureSEC source: 0001576427-16-000382 · wf-form4_147768584935680.xml · derivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,185 Underlying: Ordinary Shares · 13,185 shares Expires 2026-10-27 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 33.98 euros. The U.S. dollar equivalent of the exercise price is $36.92 using the Federal Reserve Bank of New York noon buying rate for October 21, 2016 (1.00 = $1.0866). F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 16:40 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionRestricted Stock Units · Derivative | 4,057 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000873044-16-000233 · edgardoc.xml · derivative · entry 2 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,171 Underlying: Common Stock · 4,057 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 8, 2016, December 8, 2016, March 8, 2017 and June 8, 2017, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests. F2 · derivative.expiration_date: N/A Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 16:40 UTC | RADISYS CORP RSYS · Entity 161880 | Exercise / conversionCommon Stock | 4,057 | $0.00 | $0.00 |
DisclosureSEC source: 0000873044-16-000233 · edgardoc.xml · nonDerivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.